Back
Puma Biotechnology Vs. CytomX Therapeutics Industry Stock Comparison
Buy
52
PBYI
Puma Biotechnology
Last Price:
4.84
Seasonality Move:
31.31%
Buy
60
CTMX
CytomX Therapeutics
Last Price:
4.17
Seasonality Move:
-10.81%
Buy
52
Puma Biotechnology (PBYI)
is a Buy
Is Puma Biotechnology a Buy, Sell or Hold?
- The current Puma Biotechnology [PBYI] share price is $4.75. The Score for PBYI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- PBYI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
CytomX Therapeutics (CTMX)
is a Buy
Is CytomX Therapeutics a Buy, Sell or Hold?
- The current CytomX Therapeutics [CTMX] share price is $4.08. The Score for CTMX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- CTMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PBYI Stock Price Chart
What is Puma Biotechnology's stock price today?
-
The Puma Biotechnology share price today is $4.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBYI is experiencing buying pressure, which is a positive indicator for future bullish movement.
CTMX Stock Price Chart
What is CytomX Therapeutics's stock price today?
-
The CytomX Therapeutics share price today is $4.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTMX is experiencing selling pressure, which indicates risk of future bearish movement.
PBYI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 39.99 | Sell |
| Chaikin Money Flow: | 209108 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.86 - 5.46) | Sell |
| Bollinger Bands (100): | (4.45 - 5.89) | Sell |
CTMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 69.23 | Buy |
| Chaikin Money Flow: | -4173797 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.3 - 3.48) | Buy |
| Bollinger Bands (100): | (1.25 - 2.63) | Buy |
PBYI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.9 | Sell |
| 20-day SMA: | 5.06 | Sell |
| 50-day SMA: | 5.3 | Sell |
| 200-day SMA: | 4.23 | Buy |
| 8-day EMA: | 4.86 | Sell |
| 20-day EMA: | 5.02 | Sell |
| 50-day EMA: | 5.17 | Sell |
| 200-day EMA: | 4.52 | Buy |
CTMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.42 | Buy |
| 20-day SMA: | 2.47 | Buy |
| 50-day SMA: | 2.35 | Buy |
| 200-day SMA: | 1.67 | Buy |
| 8-day EMA: | 3.62 | Buy |
| 20-day EMA: | 2.85 | Buy |
| 50-day EMA: | 2.36 | Buy |
| 200-day EMA: | 1.87 | Buy |
Puma Biotechnology Earnings Growth & PBYI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and an increase next year of $0.11 per share.
CytomX Therapeutics Earnings Growth & CTMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.19 per share.
Puma Biotechnology Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CytomX Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||